Company: MYSEW
Filing Date: 2025-11-13
Form Type: 10-Q
Source: 0001213900-25-110045
Chunk: 135

Company: Myseum, Inc.
Filing Date: 2025-11-13
Form: 10-Q
Item: Part I, Item 8
Chunk 135
---
, respectively, an increase of $48,023, or 4.1%. During
the three months ended September 30, 2025 and 2024, after adjusting net loss for the net (income) loss of subsidiary attributable to noncontrolling
interest of $30,004 and $(88,343), respectively, net loss attributable to common shareholders of was $1,201,477, or ($0.28) per common
share (basic and diluted) and $1,271,801 or ($0.42) per common share (basic and diluted), respectively, a decrease of $70,324, or 5.5%.

During the nine months ended September 30, 2025
and 2024, our net loss was $4,207,780 and $3,949,373, respectively, an increase of $258,407, or 6.5%. During the nine months ended September
30, 2025 and 2024, after adjusting net loss for the net loss of subsidiary attributable to noncontrolling interest of $316,235 and $556,513,
respectively, net loss attributable to common shareholders of was $3,891,545, or ($0.93) per common share (basic and diluted) and $3,392,860,
or ($1.15) per common share (basic and diluted), respectively, an increase of $498,685, or 14.7%.

Liquidity, Capital Resources and Plan of Operations 

The accompanying unaudited consolidated financial
statements have been prepared on the basis of continuity of operations, realization of assets and the satisfaction of liabilities and
commitments in the ordinary course of business. As of September 30, 2025, we had cash and cash equivalents of $457,626, short-term investments
of $4,346,310, and working capital of $4,193,316. Short-term investments include U.S. Treasury zero coupon bills that are all highly rated
and have initial maturities between two and eight months. On January 8, 2025, the Company entered into a securities purchase agreement
(the “Purchase Agreement”) with certain institutional investors pursuant to which the Company agreed to sell to such investors
1,200,000 shares of common stock of the Company at a purchase price of $4.25 per share of Common Stock (the “Offering”). The
closing of the sales of these securities under the Purchase Agreement took place